Spark Therapeutics

In May 2014, Deerfield invested in Spark Therapeutics through a $72.8 million Series B financing. Spark is a private clinical stage gene therapy company based in Philadelphia, PA and spun out of the Children’s Hospital of Philadelphia (CHOP).